AI-powered brain zaps aim to slow language loss in dementia
NCT ID NCT07511179
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a personalized brain stimulation device for people with primary progressive aphasia (PPA), a condition that slowly destroys language abilities. Ten participants will receive daily 30-minute sessions over three weeks, where an AI analyzes their brain activity and adjusts the stimulation in real time while they do memory exercises. The goal is to see if this approach can improve word recall and thinking skills, and whether it could eventually be used at home.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- transcranial electrical stimulation (tES) device
- What this could lead to
- If it works, this could point toward a non-invasive, home-based therapy to help people with PPA retain language and memory skills longer.
- What could go wrong
- This is a very small, early feasibility study with only 10 participants, so results may not apply to everyone. The treatment is short-term and may not produce lasting benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PPA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.